Genes & Diseases· 2016Q1· Review
Temozolomide resistance in glioblastoma multiforme
- 1,170citations
- Q1SCImago
- 2016year
Short summary
Glioblastoma cells develop resistance to temozolomide (TMZ) through mechanisms like MGMT expression or DNA repair pathway deficiencies, with intrinsic and acquired resistance characteristics not yet systematically compared.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Genetics
GeneticsMedicine